Lung Cancer: The addition of chemotherapy to EGFR inhibitor therapy improved survival in advanced EGFR-mutant NSCLC in two independent studies, compared with targeted therapy alone

by OncoDNA

The addition of chemotherapy to EGFR inhibitor therapy improved survival in advanced EGFR-mutant NSCLC in two independent studies, compared with targeted therapy alone

Read more

LUNG CANCER: Despite early encouraging results, the EGFR inhibitor poziotinib failed to meet its primary endpoint in the phase II ZENITH20 tria

by OncoDNA

Despite early encouraging results, the EGFR inhibitor poziotinib failed to meet its primary endpoint in the phase II ZENITH20 trial. For patients with pre-treated NSCLC with EGFR exon 20 insertion mut...

Read more

La inhibición combinada de EGFR y C-RAF induce la regresión de tumores de páncreas

by Revista Genética Médica

El adenocarcinoma pancreático ductal (PDAC), con una tasa de supervivencia a 5 años de tan sólo un 7%, es la tercera causa de muerte relacionada con el cáncer en todo el mundo.

Read more

Scientists discover an essential role for a cell signaling pathway that regulates the early stages of liver regeneration and cancer

by IBEC - Institut de Bioenginyeria de Catalunya

The results show, on one hand, that the activation of the EGFR pathway is crucial during the early stages of liver regeneration following surgical resection of a large part of the organ. Indeed, mice ...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

CSIC Scientists propose a new strategy t...

by CSIC - Centro Superior de Investigaciones Científicas

A study performed by researchers at the Institute for Advanced Chemist...

Photos Stream